Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data

BACKGROUND: In 2010, the Clinical and Laboratory Standards Institute (CLSI) lowered susceptibility breakpoints for carbapenem agents, though few studies have evaluated the clinical impact of these changes. The objective of this study was to determine whether a clinical breakpoint exists for carbapen...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donnell, J Nicholas, Rhodes, Nathaniel, Biehle, Lauren R, Patel, Twisha, McLaughlin, Milena, Esterly, John, Hirsch, Elizabeth B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632156/
http://dx.doi.org/10.1093/ofid/ofx163.649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632156/
http://dx.doi.org/10.1093/ofid/ofx163.649

Ejemplares similares